Piper Sandler Maintains Overweight on Coca-Cola, Raises Price Target to $95
Piper Sandler Maintains Overweight on Coca-Cola, Raises Price Target to $95
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Piper Sandler Maintains Overweight on Coca-Cola, Raises Price Target to $95
8 Financials Stocks With Whale Alerts In Today’s Session
9 Consumer Discretionary Stocks With Whale Alerts In Today’s Session
10 Information Technology Stocks Whale Activity In Today’s Session
TD Cowen Maintains Buy on Coca-Cola, Raises Price Target to $100
JP Morgan Maintains Overweight on Boeing, Raises Price Target to $290
JP Morgan Maintains Overweight on Coca-Cola, Raises Price Target to $96
'Sam Altman To Meet With White House’s Wiles This Week Ahead Of AI Framework Deadline' - CNBC
Apple Stock Hits All-Time Highs: What's Happening?
Apple Q3 Preview: Stock Hits All-Time Highs, Will Earnings Justify the Momentum?
Shares of software companies are trading higher as the industry extends its recent rally, which may be due to investors rotating out of weakened semiconductor and AI hardware stock…
Apple Could Swing $170 Billion In Value After Earnings
Steve Eisman Says He'd Be 'Petrified' Running OpenAI or Anthropic as Cheap Chinese Models Threaten Price War
Microsoft Q4 Adj. EPS $4.74 Beats $4.24 Estimate, Sales $90.007B Beat $87.621B Estimate
Microsoft CEO Satya Nadella Said, :This year, Azure revenue surpassed $100 billion for the first time, and Microsoft 365 Copilot reached over 30 million paid seats, reflecting the …
Microsoft Q4 Earnings Highlights: 14th Straight Double Beat, Cloud Revenue Up 27%
Microsoft shares are trading higher after the company reported better-than-expected Q4 financial results.
'Goldman Pitches $5.4 Billion Debt for Microsoft-Tied Data Center' - Bloomberg
Johnson & Johnson Says 2026 Adj Operational EPS And Adj EPS Expected To Decrease By $0.64; 2027 Adj Operational EPS And Adj EPS Expected To Decrease By $1.36
Johnson & Johnson Partners With Sail Biomedicines On In Vivo CAR-T Therapies, Secures $2.58B Acquisition Option; To Invest $785M In Sail, Expects The Agreements To Dilute Adjusted…